3.8 Article

A case of minimal change nephrotic syndrome with pregnancy

Journal

CEN CASE REPORTS
Volume 10, Issue 3, Pages 315-319

Publisher

SPRINGER JAPAN KK
DOI: 10.1007/s13730-020-00568-5

Keywords

Minimal change nephrotic syndrome; Pregnancy; Generalized alopecia

Funding

  1. Yokohama Foundation for Advancement of Medical Science
  2. Uehara Memorial Foundation
  3. Kanae Foundation for the Promotion of Medical Science
  4. Japan Society for the Promotion of Science, SEN-SHIN Medical Research
  5. MSD Life Science Foundation International
  6. Salt Science Research Foundation [18C4, 19C4, 20C4]
  7. Cardiovascular Research Fund, Tokyo
  8. Strategic Research Project of Yokohama City University
  9. Japan Agency for Medical Research and Development (AMED)
  10. Translational Research program, Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT) from AMED

Ask authors/readers for more resources

The case report presented a pregnant woman with MCNS during organogenesis, highlighting the importance of early treatment for MCNS patients to achieve a good prognosis for both mother and child.
A 32-year-old Japanese woman at 8 weeks of gestation was admitted to our hospital for systemic edema, hypoalbuminemia, and severe proteinuria. The patient had a history of generalized alopecia and migraine. We diagnosed nephrotic syndrome, and renal biopsy revealed minimal change nephrotic syndrome (MCNS). We administered 1000 mg/day of methylprednisolone for 3 days. Oral corticosteroid therapy was followed by 40 mg of prednisolone daily. We carefully selected concomitant medication after considering organogenesis. Before and after renal biopsy, we administered heparin, antithrombin III, and immunoglobulin agents as appropriate. The patient achieved complete remission on day 8 of treatment and gave birth to a boy at 37 weeks of gestation without recurrence. MCNS during pregnancy is rare, and there is no established treatment. In conclusion, we present a case of a pregnant woman with MCNS during organogenesis. Early treatment initiation can provide a good prognosis for both mother and child.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available